First sessions: Afternoon of September 15
Four individual slots available, more may be provided based on demand. First come, first served.
To help McGill neuroscience researchers move their innovations towards commercialization, NeuroSphere is pleased to offer office hours focused on neuroscience drug development.
Register to meet with Dr. Francine Gervais (consultant/senior executive in pharmaceutical development) in a 45 minute Zoom one-on-one to get advice on how to address potential challenges in drug discovery and development. Dr. Gervais is under NDA with McGill University.
- Available to McGill principal investigators
- In preparation for your meeting with Dr. Gervais, you will be asked to provide NeuroSphere with a short project description (1-2 pages or a slide deck) by September 10 at 5:00 p.m.